U.S. FDA Says Global Drug Safety On Importers’ Shoulders
This article was originally published in PharmAsia News
Executive Summary
U.S. FDA is grappling with the challenges of import safety as the number of foreign-sourced drugs entering the country exceeds FDA's inspection capabilities, and the agency hopes two risk-based draft guidances will increase industry accountability and free up resources for high-risk inspections